Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review

Published by Global Data on 3rd January 2019 | Ref: 1127928 | This Report Is In Stock

$125 | Single User
$250 | Site License
$375 | Enterprise License
$125 | Single User
$250 | Site License
$375 | Enterprise License


Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – GlobalData’s summarization of the company’s business strategy.

- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.


Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures and markets a range of pharmaceutical products worldwide. The company develops and manufactures branded generic products. It also manufactures active pharmaceutical ingredients (APIs) primarily for use in manufacturing of pharmaceutical products. Emcure has presence in all major therapeutic areas including cardiology, pain and analgesics, HIV, gynecology, blood related, anti-infective, nephrology, diabetes and cancer among others as well as vitamins, minerals and nutrients products. It operates in Brazil, Dubai, South Africa, Singapore and Nigeria. The company has branch offices in Russia and Morocco. Emcure is headquartered in Pune, Maharashtra, India.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1 - About the Company 5

Emcure Pharmaceuticals Ltd - Key Facts 5

Emcure Pharmaceuticals Ltd - Key Employees 6

Emcure Pharmaceuticals Ltd - Key Employee Biographies 7

Emcure Pharmaceuticals Ltd - Major Products and Services 8

Emcure Pharmaceuticals Ltd - History 9

Emcure Pharmaceuticals Ltd - Company Statement 11

Emcure Pharmaceuticals Ltd - Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2 – Company Analysis 14

Company Overview 14

Emcure Pharmaceuticals Ltd - Business Description 15

Emcure Pharmaceuticals Ltd - Corporate Strategy 16

Emcure Pharmaceuticals Ltd - SWOT Analysis 17

SWOT Analysis - Overview 17

Emcure Pharmaceuticals Ltd - Strengths 17

Emcure Pharmaceuticals Ltd - Weaknesses 18

Emcure Pharmaceuticals Ltd - Opportunities 19

Emcure Pharmaceuticals Ltd - Threats 20

Emcure Pharmaceuticals Ltd - Key Competitors 21

Section 3 – Company’s Lifesciences Financial Deals and Alliances 22

Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019 22

Emcure Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019 23

Emcure Pharmaceuticals Ltd, Recent Deals Summary 24

Section 4 – Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25

Additional Details


Global Data

Publisher Information


1127928 | GDPH141651SA

Number of Pages


Report Format


This report is published by Global Data

Download Free Report Summary PDF

Emcure Pharmaceuticals Ltd - Strategic SWOT Analysis Review [Updated: 03-01-2019] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types


Buy now using our secure payment system.